Nycomed Amersham received the Queen’s Award for Enterprise, which is given in recognition for a company’s outstanding achievement in technology, exports, or environmental performance. Queen Elizabeth grants the awards on her April 21st
Nycomed Amersham received the Queens Award for Enterprise, which is given in recognition for a companys outstanding achievement in technology, exports, or environmental performance. Queen Elizabeth grants the awards on her April 21st birthday.
The companys headquarters are located in the U.K. while its North American operations are headquartered in Princeton, NJ.
The companys U.K. imaging business group won the award for its continuous achievement in export sales from 1994 to 1999. During this time, Nycomeds British exports more than doubled. Over half of Nycomeds success came through sales from the U.S. office. Myoview, a heart imaging agent, and OncoSeed, a treatment for prostate cancer, were best-sellers, said Daniel L. Peters, Nycomed Imagings U.S. president. The company has won the Queens Award 14 times in the last 33 years.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.